Literature DB >> 23365054

Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications.

Alexander Storch1, Christine B Schneider, Martin Wolz, Yannic Stürwald, Angelika Nebe, Per Odin, Andreas Mahler, Gerd Fuchs, Wolfgang H Jost, K Ray Chaudhuri, Rainer Koch, Heinz Reichmann, Georg Ebersbach.   

Abstract

OBJECTIVE: To evaluate frequency, severity, and correlation of nonmotor symptoms (NMS) with motor complications in fluctuating Parkinson disease (PD).
METHODS: The Multicenter NonMotor Fluctuations in PD cross-sectional study used clinical examination of 10 NMS (dysphagia, anxiety, depression, fatigue, excessive sweating, inner restlessness, pain, concentration/attention, dizziness, bladder urgency) quantified using a visual analogue scale (VAS) in motor-defined on (NMS(On)) and off state (NMS(Off)) combined with motor assessments and self-ratings at home in 100 patients with advanced PD.
RESULTS: All NMS except dysphagia, excessive sweating, and bladder urgency fluctuated in conjunction to motor fluctuations with more frequent and severe symptoms in off compared to on state. The proportions of patients experiencing autonomic/sensory NMS in both motor states were similar to those with these NMS exclusively in off state (ratios 0.4-1.3), while for mental/psychic NMS the proportions with exclusive manifestation in off state were higher (ratios 1.8-3.1). Demographic and clinical characteristics correlated neither with NMS frequency patterns and severities nor with ΔNMS(On/Off) severities (defined as the differences of VAS scores between on and off). Severities of NMS(on), NMS(Off), and ΔNMS(On/Off) did not correlate with motor function. Presence of anxiety, depression, fatigue, and pain had negative impact on health-related quality of life (HRQOL) measured by Parkinson's Disease Questionnaire-8 scoring independent of their occurrence with respect to motor state. Fluctuations of these NMS but not of fatigue deteriorated HRQOL.
CONCLUSION: Patterns of NMS fluctuations are heterogeneous and complex, but psychic NMS fluctuate more frequently and severely. Demographic parameters and motor function do not correlate with NMS or nonmotor fluctuation severities in fluctuating PD.

Entities:  

Mesh:

Year:  2013        PMID: 23365054     DOI: 10.1212/WNL.0b013e318285c0ed

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  94 in total

1.  Post-stroke fatigue: a deficit in corticomotor excitability?

Authors:  Annapoorna Kuppuswamy; Ella V Clark; Isobel F Turner; John C Rothwell; Nick S Ward
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

Review 2.  Modern treatment in Parkinson's disease, a personal approach.

Authors:  Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-21       Impact factor: 3.575

3.  Assessment of Duodopa® effects on quality of life of patients with advanced Parkinson's disease and their caregivers.

Authors:  Rosella Ciurleo; Francesco Corallo; Lilla Bonanno; Viviana Lo Buono; Giuseppe Di Lorenzo; Roberta Versaci; Cettina Allone; Rosanna Palmeri; Placido Bramanti; Silvia Marino
Journal:  J Neurol       Date:  2018-06-27       Impact factor: 4.849

4.  A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease.

Authors:  Kallol Ray Chaudhuri; Antoniya Todorova; Melissa J Nirenberg; Miriam Parry; Anne Martin; Pablo Martinez-Martin; Alexandra Rizos; Tove Henriksen; Wolfgang Jost; Alexander Storch; Georg Ebersbach; Heinz Reichmann; Per Odin; Angelo Antonini
Journal:  Mov Disord Clin Pract       Date:  2015-03-16

Review 5.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

Review 6.  [Nonmotor symptoms in Parkinson's disease].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

Review 7.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

8.  Tolcapone addition improves Parkinson's disease associated nonmotor symptoms.

Authors:  Thomas Müller
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 9.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

10.  Assessment of Wearing Off in Parkinson's disease using objective measurement.

Authors:  Parisa Farzanehfar; Holly Woodrow; Malcolm Horne
Journal:  J Neurol       Date:  2020-09-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.